146 related articles for article (PubMed ID: 37000716)
21. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
[TBL] [Abstract][Full Text] [Related]
22. Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010.
Thoon KC; Chong CY; Tee NW
Int J Infect Dis; 2012 Mar; 16(3):e209-15. PubMed ID: 22281191
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
[TBL] [Abstract][Full Text] [Related]
24. Lower respiratory infections mortality among Brazilians under-five before and after national pneumococcal conjugate vaccine implementation.
Camargos P; Nascimento-Carvalho CM; Teixeira R; França E
Vaccine; 2020 Mar; 38(11):2559-2565. PubMed ID: 32033849
[TBL] [Abstract][Full Text] [Related]
25. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study.
Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang AB
Lancet Child Adolesc Health; 2020 Jun; 4(6):425-434. PubMed ID: 32450122
[TBL] [Abstract][Full Text] [Related]
26. Physician perspectives regarding pneumococcal conjugate vaccine.
Schaffer SJ; Szilagyi PG; Shone LP; Ambrose SJ; Dunn MK; Barth RD; Edwards K; Weinberg GA; Balter S; Schwartz B
Pediatrics; 2002 Dec; 110(6):e68. PubMed ID: 12456935
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China.
Mo X; Gai Tobe R; Liu X; Mori R
Pediatr Infect Dis J; 2016 Nov; 35(11):e353-e361. PubMed ID: 27753771
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in pneumococcal vaccination of children.
Russell FM; Mulholland EK
Ann Trop Paediatr; 2004 Dec; 24(4):283-94. PubMed ID: 15720885
[TBL] [Abstract][Full Text] [Related]
30. Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage.
Roca A; Bottomley C; Hill PC; Bojang A; Egere U; Antonio M; Darboe O; Greenwood BM; Adegbola RA
Clin Infect Dis; 2012 Sep; 55(6):816-24. PubMed ID: 22700830
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.
Andrade AL; Minamisava R; Policena G; Cristo EB; Domingues CM; de Cunto Brandileone MC; Almeida SC; Toscano CM; Bierrenbach AL
Hum Vaccin Immunother; 2016; 12(2):285-92. PubMed ID: 26905679
[TBL] [Abstract][Full Text] [Related]
32. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.
van Gils EJ; Veenhoven RH; Hak E; Rodenburg GD; Bogaert D; Ijzerman EP; Bruin JP; van Alphen L; Sanders EA
JAMA; 2009 Jul; 302(2):159-67. PubMed ID: 19584345
[TBL] [Abstract][Full Text] [Related]
33. Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: Time series analyses.
Jimbo Sotomayor R; Toscano CM; Sánchez Choez X; Vilema Ortíz M; Rivas Condo J; Ghisays G; Haneuse S; Weinberger DM; McGee G; de Oliveira LH
Vaccine; 2020 Oct; 38(45):7033-7039. PubMed ID: 32981782
[TBL] [Abstract][Full Text] [Related]
34. Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study.
Lourenço J; Obolski U; Swarthout TD; Gori A; Bar-Zeev N; Everett D; Kamng'ona AW; Mwalukomo TS; Mataya AA; Mwansambo C; Banda M; Gupta S; French N; Heyderman RS
BMC Med; 2019 Dec; 17(1):219. PubMed ID: 31801542
[TBL] [Abstract][Full Text] [Related]
35. Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine.
Payeras A; Villoslada A; Garau M; Salvador MN; Gallegos MC
Int J Infect Dis; 2015 Apr; 33():22-7. PubMed ID: 25541296
[TBL] [Abstract][Full Text] [Related]
36. Estimated impact of the pneumococcal conjugate vaccine on pneumonia mortality in South Africa, 1999 through 2016: An ecological modelling study.
Kleynhans J; Tempia S; Shioda K; von Gottberg A; Weinberger DM; Cohen C
PLoS Med; 2021 Feb; 18(2):e1003537. PubMed ID: 33591995
[TBL] [Abstract][Full Text] [Related]
37. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.
Rozenbaum MH; Sanders EA; van Hoek AJ; Jansen AG; van der Ende A; van den Dobbelsteen G; Rodenburg GD; Hak E; Postma MJ
BMJ; 2010 Jun; 340():c2509. PubMed ID: 20519267
[TBL] [Abstract][Full Text] [Related]
38. Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic.
Kozakova J; Krizova P; Maly M
PLoS One; 2021; 16(2):e0247862. PubMed ID: 33635933
[TBL] [Abstract][Full Text] [Related]
39. Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.
McFarland M; Szasz TP; Zhou JY; Motley K; Sivapalan JS; Isaacson-Schmid M; Todd EM; Hogan PG; Fritz SA; Burnham CD; Hoffmann S; Morley SC
Vaccine; 2017 Aug; 35(34):4389-4395. PubMed ID: 28687405
[TBL] [Abstract][Full Text] [Related]
40. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006.
Lepoutre A; Varon E; Georges S; Gutmann L; Lévy-Bruhl D
Euro Surveill; 2008 Aug; 13(35):. PubMed ID: 18761883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
